The use of illustrated medication diaries to improve outcomes for children initiated on highly active antiretroviral therapy

被引:0
作者
Kannigan, Yashodhara [1 ]
Spicer, Kevin B. [1 ,2 ]
Naby, Fathima [1 ,2 ]
机构
[1] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Paediat & Child Hlth, Durban, South Africa
[2] Dept Paediat & Child Hlth, Pietermaritzburg Metropolitan Hosp Complex, Pietermaritzburg, South Africa
关键词
PATIENT DIARY; ADHERENCE; RESISTANCE; TOOL; RNA;
D O I
10.4102/sajhivmed.v19i1.804
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Human immunodeficiency virus (HIV) represents a huge burden of disease in South Africa. Highly active antiretroviral therapy (HAART) is effective in reducing HIV-related morbidity and mortality. Simple, inexpensive methods like adherence diaries to optimise effects of HAART would be useful. Methods: This quasi-experimental study was performed at a paediatric antiretroviral clinic in KwaZulu-Natal, South Africa. Children, from birth to 15 years, initiated on HAART from 01 August 2015 to 31 July 2016 were given illustrated medication diaries to be completed by caregivers. Viral load suppression and improvement in growth parameters and CD4+ percentage were determined at six months and one year. These outcomes were compared to those of a group of children who had been initiated on HAART from 01 August 2014 to 31 July 2015 and who had not received diaries. Results: Ninety-nine children were included in the historical control group and 35 children in the intervention group. Viral load suppression (HIV-1 RNA of < 400 copies/mL) was 72% in the control group and 71% in the diary group at 6 months (p = 0.6). At 12 months, 73% of children in the control group and 57% of the diary group had suppressed viral loads (p = 0.18). At 6 months, 63% of children in the control group and 57% of the diary group had improved weight for height z-scores (p = 0.09). At 12 months, when compared with baseline weight for height z-scores, there was improvement in 34% and 41% of the control and diary groups, respectively (p = 0.6). CD4+ percentages improved in 51% of the control group and 50% of the diary group at 6 months (p = 0.70); improvement was noted in 44% and 49%, respectively, at 12 months (p = 0.33). Conclusion: The addition of an illustrated medication diary to routine adherence counselling did not improve outcomes for children initiated on HAART.
引用
收藏
页数:7
相关论文
共 50 条
[41]   Highly active antiretroviral therapy adherence among perinatally infected HIV adolescents at a teaching hospital in Ghana [J].
Anokye-Kumatia, A. B. ;
Enimil, A. ;
Afriyie, D. K. ;
Tetteh, R. ;
Mensah, N. K. ;
Amo, A. A. ;
Gariba, B. B. ;
Amponsah, S. .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2018, 30 (09) :1144-1146
[42]   Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection [J].
Van Dyke, RB ;
Lee, S ;
Johnson, GM ;
Wiznia, A ;
Mohan, K ;
Stanley, K ;
Morse, EV ;
Krogstad, PA ;
Nachman, S .
PEDIATRICS, 2002, 109 (04) :e61
[43]   Risk of Viral Failure Declines With Duration of Suppression on Highly Active Antiretroviral Therapy Irrespective of Adherence Level [J].
Lima, Viviane D. ;
Bangsberg, David R. ;
Harrigan, P. Richard ;
Deeks, Steven G. ;
Yip, Benita ;
Hogg, Robert S. ;
Montaner, Julio S. G. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 55 (04) :460-465
[44]   Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome [J].
DeMasi, RA ;
Graham, NM ;
Tolson, JM ;
Pham, SV ;
Capuano, GA ;
Fisher, RL ;
Shaefer, MS ;
Pakes, GE ;
Sawyerr, GA ;
Eron, JJ .
ADVANCES IN THERAPY, 2001, 18 (04) :163-173
[45]   Adherence to highly active antiretroviral therapy in Spain. A meta-analysis [J].
Ortego, Carmen ;
Huedo-Medina, Tania Bibiana ;
Vejo, Javier ;
Javier Llorca, Francisco .
GACETA SANITARIA, 2011, 25 (04) :282-289
[46]   Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature [J].
Ammassari, A ;
Trotta, MP ;
Murri, R ;
Castelli, F ;
Narciso, P ;
Noto, P ;
Vecchiet, J ;
D'Arminio Monforte, A ;
Wu, AW ;
Antinori, A .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S123-S127
[47]   Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA [J].
Cu-Uvin, S ;
Caliendo, AM ;
Reinert, S ;
Chang, A ;
Juliano-Remollino, C ;
Flanigan, TP ;
Mayer, KH ;
Carpenter, CCJ .
AIDS, 2000, 14 (04) :415-421
[48]   Highly active antiretroviral therapy adherence and its determinants in selected regions in Indonesia [J].
Widjaja, Felix F. ;
Puspita, Caroline G. ;
Daud, Ferdi ;
Yudhistrie, Ienag ;
Tiara, Marita R. ;
Suwita, Christopher S. ;
Zain, Ekachaeryanti ;
Husna, Lailatul ;
Djauzi, Samsuridjal .
MEDICAL JOURNAL OF INDONESIA, 2011, 20 (01) :50-55
[49]   Identification, management, and prevention of adverse effects associated with highly active antiretroviral therapy [J].
Schiller, DS .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (23) :2507-2522
[50]   Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy [J].
Pence, Brian Wells ;
Miller, William C. ;
Gaynes, Bradley N. ;
Eron, Joseph J., Jr. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 44 (02) :159-166